Dave Muoio

By Dave Muoio 02:14 pm September 10, 2020
Artificial intelligence drug discovery company Recursion Pharmaceuticals has announced an oversubscribed Series D funding round totaling $239 million. Headlining the raise is a strategic partnership with Bayer, which came with a $50 million investment from the Leaps by Bayer. Casdin Capital, Catalio Capital Management, Laurion Capital Management, Samsara BioCapital and all of the major...
By Dave Muoio 02:47 pm September 9, 2020
Bardy Diagnostics, maker of cardiac-monitoring adhesive patches, announced yesterday that Kevin Hykes began serving as the company's president and CEO on August 31. Hykes was formerly the president and CEO of Relievant Medical Systems, Metaventon and Cameron Health. Earlier in his career he spent 16 years at Medtronic. As Bardy Diagnostics' new head, he'll help develop and execute the company's...
By Dave Muoio 12:28 pm September 9, 2020
Cyrus Massoumi, the cofounder and former CEO and chairman of doctor search and appointment-booking platform Zocdoc, has filed a lawsuit alleging that his fellow cofounders and the company's CFO conspired to remove him from the company through "an elaborate series of lies and deceptions." The suit, filed yesterday in New York's Supreme Court, describes a series of events leading up to a Zocdoc...
By Dave Muoio 10:48 am September 9, 2020
Oncomfort, a Belgian company using therapeutic virtual reality to relieve pain and anxiety, has raised €10 million ($11.8 million) in Series A funding. Debiopharm and Crédit Mutuel Innovation led the round, which also saw support from existing shareholders and Belgium's Walloon Region Regional Investment Company. WHAT IT DOES Oncomfort was founded in 2017, and launched its SedaKit for Digital...
By Dave Muoio 12:28 pm September 8, 2020
Health research platform maker Vibrent Health announced last week that it has received a $39 million infusion from the National Institutes of Health to continue serving as the hub of the public research organization's All of Us Research Program. Founded in 2009, Vibrent Health's technology handles large-scale data collection, storage, analysis and security for research organizations, and includes...
By Dave Muoio 03:18 pm September 4, 2020
Connected-care-device and services company VivaLNK has partnered with healthcare engineering and tech firm Mazzetti to supply pop-up hospitals, clinics and senior centers with patient monitoring tools. These include VivaLNK's wearable vitals sensors and a connected provider platform, which the companies say will help reduce unnecessary disease exposures within these settings. “As the pandemic...
By Dave Muoio 01:47 pm September 4, 2020
By pulling anonymized, publicly available location data from mobile devices, researchers have found that the U.S. population generally complied with stay-at-home orders issued by state officials this spring. The analysis, published in the CDC's Morbidity and Mortality Weekly Report (MMWR), is the latest to use personal devices and the data they generate to describe behaviors relevant to public...
By Dave Muoio 02:08 pm September 3, 2020
New data published in JAMA Cardiology suggests that the Apple Watch's ECG tool could not only be used to record multi-lead ECG, but also to spot ST-segment changes among patients with acute coronary syndromes. The independent study was conducted by researchers from Italy's Magna Graecia University, and enrolled 100 participants who had myocardial infarction or were healthy. And although taking...
By Dave Muoio 10:48 am September 3, 2020
Biofourmis, a Boston-based predictive-care startup that's leaning more and more into digital therapeutics, has wrapped up $100 million in Series C financing. The raise was led by SoftBank Vision Fund 2, and also saw contributions from prior backers Openspace Ventures, MassMutual Ventures, Sequoia Capital and EDBI. With this major jump from last May's $35 million Series B, the company is now...
By Dave Muoio 02:47 pm September 2, 2020
NeuroPace, the maker of an implanted neurostimulation therapy device for uncontrolled epileptic seizures, announced a $33 million equity raise on Monday. Accelmed Partners led the investment, which was joined by new backers such as Revelation Partners, Soleus Capital and an unnamed strategic investor. Prior backers KCK Group and OrbiMed Advisors also contributed. Alongside the equity, NeuroPace...